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Background: The purpose of this study was to investigate the influence of muscle mass and bone mineral density
on markers of mobility in dwelling elderly women.
Methods: This cross-sectional study included 99 elderly women, who were 65 years old or above, in Campinas-SP,
Brazil. To collect data, we used sociodemographic data, the body mass index (BMI), health status, comorbidities, use
of medications, mobility tests (TUG and gait speed) and examinations of the body composition (densitometry with
dual-emission X-ray absorptiometry “DXA”). In order to examine the relationship between muscle and bone mass
with mobility (gait speed and TUG), we applied the Spearman correlation coefficient.
Also was applied the analysis of covariance (ANCOVA) adjusted for age and comorbidities. To identify the factors
associated with mobility, we used the univariate and multivariate logistic regression analysis. The level of
significance for statistical tests was P < 0.05.
Results: The correlation between sarcopenia and bone mineral density with mobility tests showed a significant
relationship only between sarcopenia and TUG (r = 0.277, P = 0.006) in Spearman correlation coefficient. The result of
the correlation analysis (ANCOVA) showed that sarcopenia was associated with gait speed (r2 = 0.0636, P = 0.0018) and
TUG (r2 = 0.0898, P = 0.0027). The results of the multivariate analysis showed that age (P = 0.034, OR = 1.081) was
associated with worse performance on gait speed. By highlighting the TUG test, the results of the multivariate
analysis showed that the age (P = 0.004, OR = 1.111) and BMI in overweight (P = 0.011, OR = 7.83) and obese
(P < 0.001, OR = 7.84) women were associated with lower performance of the functionality of the lower limbs.
Conclusion: The findings with regard to mobility tests which were analyzed in this study indicate the association
of variables related to the aging process that contribute to the decline in physical performance, for example, age,
BMI and sarcopenia.
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The changes in body composition associated with aging
represent potential conditions that favor functional limita-
tions [1]. Musculoskeletal alterations trigger limitations
in mobility [2], which also extend to restrictions on the
participation in daily activities, difficulties in implementing
self-care tasks and absenteeism [3], resulting in higher
dependence [4] with negative effects on the quality of life
of older adults [5,6].* Correspondence: grfalsarella@ig.com.br
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reproduction in any medium, provided the orLoss of muscle mass and low bone mineral density are
considered as indications of functional decline [7]. The
association between sarcopenia and osteoporosis may be
due to the combination of various etiologic factors, such as
mechanical aspects; denervation; mitochondrial dysfunction;
vitamin D deficiency; low levels of testosterone, estrogens,
sulfate of dihydroepiandrostenedione (S-DHEA) and insu-
lin growth factor I (IGF-I); inflammation (elevated IL-6 and
TNF-α); and decreased food intake [8,9].
Modifications of the morphophysiological muscle tissue
favor decreases in mass, strength and muscle function,
which impacts mobility, increases the risk of falls and
contributes to fragility [9]. There are variations in the lossal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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however, this process starts at approximately 45 years old
and, above 80 years old, sarcopenia is present in more
than 50% of the elderly population [10].
Another important aspect of the body composition
related to advanced age refers to the imbalance between
bone formation and resorption that may result in decreased
bone mass. Considered as a disease that is associated with
bone remodeling, osteoporosis results in greater fragility of
the bone tissue and increases the risk of falls and fractures
in the elderly population [11,12].
Loss of mobility is one of the major consequences of the
deterioration of the musculoskeletal system. Elderly people
with restrictions on their mobility have higher rates of falls,
chronic disease, dependency, institutionalization and death
[13]. Within this framework, we highlight the importance
of assessing sarcopenia through measures of physical per-
formance, with the purpose of preventing or delaying the
onset of frailty, disability and mortality among the elderly
population [7,9,14].
Changes in the body composition related to aging are
related mainly to decreases in muscle mass and bone mass.
In this sense, the purpose of this study was to investigate the
influence of muscle mass and bone mass on the functionality
and, specifically, on markers of mobility in elderly patients.
Methods
Subjects
This cross-sectional study included 99 elderly women ≥ 65
years old, who were living in Campinas-SP, Brazil. In order
to obtain a non-institutionalized sample with a hetero-
geneous body composition, we chose to include elderly
women who were randomly recruited in a clinical environ-
ment and in the community from three different sources:
1) community-dwelling elderly participants in a survey
about frailty in elderly Brazilians (Study FIBRA Campinas);
2) elderly individuals recruited from the Reference Center
on Aging Health (CRI); and 3) ambulatory elderly indi-
viduals from the Rheumatology Department of a public
hospital in the city.
We excluded elderly individuals who had severe cognitive
impairment that would hinder the examinations, patients
with functional limitations that prevented ambulation and
patients with inflammatory rheumatic diseases. The exclu-
sion was based on the evaluation of the rheumatologist
responsible for the assessment, the statement of the elderly
people or their caregiver and/or the observation of the re-
searcher. This study was approved by the Ethics Committee
of UNICAMP with protocol number 913/2009.
Sociodemographic and anthropometric data
The investigation included the following variables: age,
education, weight, height and body mass index (BMI,
calculated according to height/weight2, following thecategorizations of the World Health Organization) [15]:
underweight (<18.5), normal (18.5-24.9), overweight (25.0-
29.9), and obese (> 30.0).
Health conditions
Patients self-reported the presence of the following chronic
conditions: cardiovascular disease, stroke, diabetes, hyper-
tension, arthritis or rheumatism, lung disease, cataracts,
depression and thyroidopathy. Health conditions were
classified into two categories, i.e., ≤4 or >4 diseases. The
reporting as to the use of medications assessed the use
of ≤4 or >4 medications per day.
Gait speed
This test represented a geriatric assessment instrument
and indicated the functions of daily life activities. The Gait
speed showed the time taken to travel a distance of 4.6
meters. Patients would walk a total distance of 4.6 meters,
with the initial 2 m and final 2 m disregarded when calcu-
lating the time spent in motion (acceleration and decele-
ration time). Three measurements were performed, and
their average value was calculated [16,17].
Functional testing of mobility and dynamic balance
“Timed Up and Go” (TUG)
This test is an effective method to evaluate the mobility
and quantify the locomotor performance [18], and it is a
predictor of the risk of falls and of the dynamic equilibrium
of the elderly people [19]. The individual is requested to rise
from a chair (45 cm) and walk as quickly and safely as
possible for 3 m in a straight line and then walk back to the
chair and sit as in the initial position. Literature categorizes
this test on three levels from the run time: ≤10 seconds
(TUG 1); between 10.01 and 20 s (TUG 2); and over
20.01 s (TUG 3) [14]; however, this research considered
the time of the test as a continuous variable.
Densitometry with dual-emission X-ray
absorptiometry (DXA)
All subjects were evaluated with the Body Dual X-ray
Absorptiometry (DXA) software version 4.7 (GE/Lunar
Radiation), model DPX-IQ. These analyses were performed
by an operator who was blinded to the study objectives.
This imaging technique evaluates body composition (muscle,
fat and bone mass) [14]. For our study, we analyzed muscle
mass and bone mineral density, which allowed the diagno-
ses of sarcopenia, osteopenia and osteoporosis.
The participants were categorized into two groups by
checking their muscle mass: normal or with sarcopenia. In
order to calculate the sarcopenia, we applied the following
formula: appendicular muscle mass/height2 (aLM/h2). The
cutoff used in this research was 5.45 kg/m2 [8,10].
In relation to bone mineral density, we calculated the
total bone mass as the individual value obtained by
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ing the standardized diagnostic criteria suggested by WHO,
the participants were separated into three groups with
respect to the number of standard deviations (SD) of the
T-score: normal (more than −1 SD), osteopenia (−1 SD
to −2.5 SD) and osteoporosis (less than - 2.5 SD) [20].
In order to perform this examination, the elderly patients
were requested to interrupt the use of medications with
calcium 48 hours before the test.
Statistical analysis
We determined the descriptive statistics. In order to exam-
ine the relationship between muscle mass and bone mineral
density with mobility tests (gait speed and TUG), we ap-
plied the Spearman correlation coefficient and ANCOVA
(adjusted for aged and comorbidity). For the univariate
and multivariate regression analysis, stepwise criterion for
variable selection, we identified the factors associated with
mobility. In this analysis, we considered the following vari-
ables: age, sarcopenia, bone mass, BMI, comorbidities and
medication. The level of significance for statistical tests was
5% or P < 0.05. Statistical analysis was used with the SAS
System for Windows (Statistical Analysis System), version
8.02.
Results
The descriptive analysis of the sample is presented in
Table 1. This research included a sample of 99 elderly
women with ages ≥ 65 years old (mean of 73.03 years
old ± 6.51). The average number of years of schooling
was 3.86 years (± 3.57); 66.67% of the sample was not
married, and 66.67% reported their race as Caucasian.
When considering the health conditions of women, 71.72%
described themselves as having four or less diseases, and
28.28% had more than four diseases. Regarding the use of
drugs administered, 45.45% used up to four medications a
day, while 54.55% used more than four medications a day.Table 1 Characterization of the sample regarding age, school
sarcopenia and BMD in elderly women*
Mean SD** Min**
Age (years) 77.03 6.51 66.00
Schooling (years) 3.86 3.57 0.00
Height (m2) 1.51 0.05 1.40
Weight (kg) 66.19 16.78 37.00
BMI (kg/m2) 29.12 7.02 16.01
Diseases 3.66 1.67 0.00
Gait speed (m/s) 6.06 2.94 3.26
TUG (s) 13.89 5.58 6.87
Sarcopenia kg/m2 7.44 1.33 5.36
Total BMD (g/cm2) 1030 120.4 762.0
*n = 99.
**sd = standard deviation, min =minimum, q1 = quartile 1, q3 = quartile 3, max =mThe body composition analysis indicated an average
BMI of 29.12 kg/m2 (±7.02). When investigating muscle
mass, we found that 68.69% of the participants not
presented with sarcopenia, and the average value of
muscle mass found in the sample was 7.44 kg/m2 (±1.33).
In relation to total bone mass, 42.42% did not show any
changes in their bones, 36.36% had osteopenia and 21.21%
had been diagnosed with osteoporosis.
The descriptive statistics reported regarding the execu-
tion time of the mobility tests showed that the average gait
speed was 6.06 (±2.94), while for the TUG test, the average
speed of the studied participants was 13.89 (±5.58).
The correlation between the variables of sarcopenia and
bone mineral density with mobility tests (gait speed and
TUG) showed a significant relationship only between
sarcopenia and TUG (r = 0.277, P = 0.006), i.e., the lower
the muscle mass, the greater the value observed in the
TUG test performance (Table 2). The analysis of covariance
in Table 3 adjusted for aged and comorbidity, showed a
significant association between sarcopenia and gait speed
(P = 0.0102) and TUG (P = 0.0027). In Table 4 the analysis
of covariance multiple for gait speed and TUG, controlling
for age and comorbidities indicated association between
sarcopenia and gait speed (r2 = 0.0636, P = 0.0018) and
TUG (r2 = 0.0898, P = 0.0027).
The univariate logistic regression analysis, which was
used to study the relationship of factors associated with
poorer performance on mobility tests, found that gait speed
was statistically significantly correlated only with advanced
age. Using a univariate analysis, it was also found that the
TUG test showed significant correlation with the variables
of BMI and sarcopenia (Table 5).
The results of the multivariate analysis with stepwise
criterion for variable selection for gait speed found that
age was associated with a worse performance on this test.
We found that elderly women of an increased age had a
higher risk for lower performance in gait speed, with theing, weight, height, bmi, comorbidities, gait speed, TUG,
Q1** Median Q3** Max**
72.00 77.00 81.00 94.00
1.00 4.00 4.00 15.00
1.47 1.51 1.53 1.67
53.10 64.50 75.50 132.00
23.37 28.77 32.68 57.89
2.00 4.00 5.00 8.00
4.18 5.16 7.17 19.72
9.98 12.43 16.16 36.04
6.32 7.33 8.11 11.29
940.0 1037 1123 1283
aximum.
Table 2 Correlation between muscle mass and bone mass
with gait speed and TUG
Sarcopenia Total BMD (g/cm2) Total adult2Tscore
Gait speed* r = 0.18281 0.06163 0.08019
n = 98 P = 0.0716 0.5466 0.432
TUG 0.27749 0.15157 0.14129
n = 96 0.0062 0.1404 0.1697
*r = Spearman correlation coefficient; P = P value; n = number of subjects.
Table 4 Analysis of covariance multiple for gait speed
and TUG, controlling for age and comorbidities
Gait speed
Sarcopenia Beta (EP) P* R2 Parcial
Continuous variable 11.84 (3.68) 0.0018 0.0636
TUG
Sarcopenia Beta (EP) P* R2 Parcial
Continuous variable 6.538 (2.121) 0.0027 0.0898
*Value-p refers to ANCOVA, adjusted for aged and comorbidity.
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of age, (Table 6).
By highlighting the TUG test, the result of the multivari-
ate analysis showed that age and BMI were associated with
lower performance of the functionality of the lower limbs.
The elderly women who had a worse performance on the
test (and thus, were at higher risk) had an increased age
(each year of age increased the risk by 11.1%) and BMI
(overweight patients had 7.8 times greater risk of mobility
limitation, and obese patients had 7.5 times greater risk)
(Table 6).
Discussion
The aging process is characterized by a gradual decline
in the physical function [9]; however, it is not entirely
clear whether the reduction in the physical function is the
exclusive result of changes in body composition [1]. Epi-
demiological studies have shown inconsistent results when
examining the influence of muscle mass and bone mineral
density on physical performance in older adults [1,21,22].
Therefore, this research examined the influence of muscle
mass and bone mass on the functionality of the lower limbs
and found a correlation among components of the body
composition and mobility in the elderly patients. In the in-
vestigated sample, the lower muscle mass was associated
with reduced physical performance on the gait speed and
TUG test. This finding is extremely important because
muscle mass represents a modifiable physiological param-
eter, which can be altered through interventions.
Considered as a metabolic and functional component,
the body composition undergoes important changes with
age, which are expressed mainly by negative variation in
fat-free mass and positive variation in fat mass [23], with
repercussion on the physical performance in the old ageTable 3 Analysis covariance between muscle mass and
bone mass with gait speed and TUG
Gait speed TUG
Sarcopenia P* Sarcopenia P*
Continuous variable 0.0102 Continuous variable 0.0027
Total BMD (g/cm2) P* Total BMD (g/cm2) P*
Continuous variable 0.2910 Continuous variable 0.0644
*Value-p refers to ANCOVA, adjusted for aged and comorbidity.[1]. Thus, a decreased mobility is strongly associated
with changes in the body composition, restrictions in par-
ticipation and increased risk of hospitalization. Physical
limitation is a strong predictor of reduced quality of life in
the old age [24,25].
Evidence suggests that changes in the body composition
contribute to the onset and progression of the disability in
the elderly patients [8]. Shin et al. [1] found that fat-free
mass is an independent predictor of functional capacity
limitation. Reid et al. [13] added that muscle mass is
strongly associated with muscle strength and mobility
in individuals with advanced age, that is, less muscle mass
in the lower extremities indicates greater risk of a decline
in mobility.
A survey conducted by Frisoli et al. [8], which analyzed
studies on the cross-sectional area of the muscles of the
lower limbs, found that elderly patients in the lowest quar-
tile for this component of body composition were more
likely to have mobility limitations. In addition, low muscle
mass was also linked with worse balance and an increased
risk of falls and disability.
With age, there is a change in the composition of
muscle tissue and a consequent change in muscle function.
This effect triggers loss of type I muscle fibers and a
marked reduction in type II muscle fibers, resulting in
decreased muscle strength that affects the performance of
everyday tasks, such as getting up from a chair, climbing
stairs, and reorganizing the body posture after a loss of
balance [9].
However, when applied to multivariate analysis, an asso-
ciation between TUG performance with age and BMI was
found; only age represented a risk factor for gait speed. In
our study, the influence of age in the mobility was similar
to the results from other surveys [19,24]. According to
Hayes and Johnson [19], there is a tendency for the
execution time for mobility to increase considerably
with advancing age. Among the possible causes related to
aging that interfere with locomotion are loss of balance,
decreased range of motion [26], presence of depressive
symptoms and decline in cognitive functions [18,19].
Considering the age, this is a variable associated with
sarcopenia, lower bone mineral density and, therefore, it
is an indication of osteopenia and osteoporosis [8,14,15].
Table 5 Univariate logistic regression analysis for gait speed and TUG
Gait speed TUG
Variables OR* CI 95% OR* P OR** CI 95% OR** P
Age
Continuous variable 1.081 1.006-1.161 0.034 1.052 0.988-1.120 0.113
Sarcopenia
No (ref.) 1.00 - - 1.00 - -
Yes 0.61 0.22-1.71 0.345 0.31 0.13-0.75 0.010
Total bone mass
Normal (ref.) 1.00 - - 1.00 - -
Osteopenia 0.39 0.12-1.24 0.111 0.42 0.17-1.06 0.066
Osteoporosis 1.49 0.46-4.51 0.483 1.09 0.36-3.29 0.886
BMI
Normal (ref.) 1.00 - - 1.00 - -
Underweight 1.24 0.27-5.68 0.786 0.55 0.17-1.76 0.310
Overweight 1.97 0.36-0.82 0.436 7.29 1.51-35.08 0.013
Obese 2.72 0.78-9.49 0.116 5.43 1.75-16.85 0.003
Comorbidities
0-4 diseases (ref.) 1.00 - - 1.00 - -
>4 diseases 0.78 0.27-2.23 0.646 1.21 0.49-2.98 0.685
Medication number
0-4 (ref.) 1.00 - - 1.00 - -
>4 1.38 0.55-3.48 0.492 1.33 0.60-2.98 0.486
*OR (odds ratio) = ratio of risk for poor performance (n = 73 elderly women with good performance and n = 25 elderly women with worse performance); CI 95%,
OR = 95% interval of confidence for the risk ratio; ref: reference level; n = 98.
**OR (odds ratio) = ratio of risk for poor performance (n = 24 elderly women with TUG 1 (≤10 s), n = 59 elderly women with TUG 2 (10.01 - 20 s) and n = 13 with
TUG 3 (over 20.01 s)); CI 95% OR = 95% interval of confidence for the risk ratio; ref: reference level Proportional hazards model. n = 96.
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that the assessment of relative sarcopenia (muscle mass
adjusted for appendicular body mass) is clinically and
physiologically more relevant when compared with absolute
sarcopenia (appendicular muscle mass adjusted for height)Table 6 Multivariate logistic regression analysis for gait
speed and TUG
Gait speed TUG




0.034 1.081 1.006-1.161 0.004 1.111 1.034 -1.194
BMI
Normal (ref.) - 1.00 -
Underweight 0.158 0.41 0.12-1.42
Overweight 0.011 7.83 1.60-38.27
Obese <0.001 7.84 2.31-24.21
*OR (odds ratio) = ratio of risk for poor performance (n = 73 with good
performance and n = 25 with worse performance); CI 95% OR = 95% interval of
confidence for the risk ratio. Stepwise criterion for variable selection; n = 98.
**OR (odds ratio) = ratio of risk for poor performance (n = 24 with TUG 1
(≤10 s), n = 59 with TUG 2 (10.01 – 20 s) and n = 13 with TUG 3 (over 20.01 s)).
Proportional hazards model. CI 95% OR = 95% interval of confidence for the
risk ratio. Stepwise criterion for variable selection; n = 96.as a stronger indicator of mobility performance in elderly
women [7].
Our research has shown BMI as a risk factor for lower
performance in mobility on the TUG test. Despite con-
troversies with regard to BMI and lean mass and bone
mass, as independent variables, and also limiting the use
of BMI as an indicator of fat mass, studies indicate an
association between BMI and the physical performance
in the elderly people [1,22]. A study [22] conducted in
Hong Kong in 4,000 elderly communities observed that the
group of older people with normal weight (BMI = 18.5-
22.9 kg/m2) needed less time to perform the 6 m walking
test compared with other BMI groups. According to the
authors, this result suggests the influence of fat mass on
functional limitation in elderly people.
Bohannon et al. [27] also indicated a significantly negative
relationship between physical function and anthropometric
parameters, such as BMI, waist circumference and waist-
hip ratio. In the Nutrition and Function Study, elder and
obese patients were twice as likely to have lower perform-
ance when analyzing the function of the lower limbs [28].
The findings regarding mobility tests which were an-
alyzed in this study may indicate the influence of other
variables related to the aging process that contribute to
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[1,22], fat mass [22,27], balance and visual disorders,
medications and comorbidities [1].
This study had some limitations. It is necessary that
other investigations with larger samples clarify whether
sarcopenia, osteopenia and osteoporosis in isolation are
associated with poor performance on mobility tests or
whether the relationship exists only with the interaction
of minor muscles and low mineral density bone. It is also
important that other studies analyze the impact of fat infil-
tration within the muscle tissue due to the extent to which
this interpretation represents a better predictor of physical
performance in older adults. Furthermore, were included
elderly with chronic diseases, among them some that can
affect body composition, such as thyroid.Conclusion
The findings with regard to mobility tests which were
analyzed in this study indicate the association of vari-
ables related to the aging process that contribute to the
decline in physical performance, for example, age, BMI
and sarcopenia.
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